Reported Standalone quarterly numbers for Mercury Laboratories are: Net Sales at Rs 18.19 crore in September 2024 down 20.04% from Rs. 22.76 crore in September 2023. Quarterly Net Profit at Rs. 0.50 crore in September 2024 down 66.81% from Rs. 1.51 crore in September 2023. EBITDA stands at Rs. 1.51 crore in September 2024 down 47.02% from Rs. 2.85 crore in September 2023.

Nifty staged a strong comeback this week, surging past the 200-day moving average and trapping bearish sellers. The index found support at its 50-week moving average, forming a bullish hammer pattern. While facing resistance at 24,000, positive sentiment prevails with increased FPI long positions and declining open interest. A sustained move above 24,000 could propel Nifty towards 24,500–24,700.

Reported Standalone quarterly numbers for Ind-Swift are: Net Sales at Rs 136.35 crore in September 2024 up 17.62% from Rs. 115.92 crore in September 2023. Quarterly Net Profit at Rs. 4.11 crore in September 2024 up 138.41% from Rs. 10.71 crore in September 2023. EBITDA stands at Rs. 19.03 crore in September 2024 up 33.17% from Rs. 14.29 crore in September 2023.

Reported Standalone quarterly numbers for Medicamen Biotech are: Net Sales at Rs 42.84 crore in September 2024 up 0.41% from Rs. 42.67 crore in September 2023. Quarterly Net Profit at Rs. 2.27 crore in September 2024 down 24.66% from Rs. 3.01 crore in September 2023. EBITDA stands at Rs. 6.84 crore in September 2024 up 1.94% from Rs. 6.71 crore in September 2023.

Reported Standalone quarterly numbers for Kernex Microsystems (India) are: Net Sales at Rs 41.16 crore in September 2024 up 4893.89% from Rs. 0.82 crore in September 2023. Quarterly Net Profit at Rs. 7.25 crore in September 2024 up 269.99% from Rs. 4.26 crore in September 2023. EBITDA stands at Rs. 10.88 crore in September 2024 up 472.6% from Rs. 2.92 crore in September 2023.

Reported Standalone quarterly numbers for Patidar Buildcon are: Net Sales at Rs 0.29 crore in September 2024 up 352.93% from Rs. 0.06 crore in September 2023. Quarterly Net Loss at Rs. 0.08 crore in September 2024 down 424.58% from Rs. 0.02 crore in September 2023. EBITDA stands negative at Rs. 0.07 crore in September 2024 down 450% from Rs. 0.02 crore in September 2023.

Reported Standalone quarterly numbers for Vista Pharmaceuticals are: Net Sales at Rs 2.49 crore in September 2024 down 28.1% from Rs. 3.47 crore in September 2023. Quarterly Net Loss at Rs. 0.97 crore in September 2024 up 51.78% from Rs. 2.02 crore in September 2023. EBITDA stands negative at Rs. 0.82 crore in September 2024 up 24.77% from Rs. 1.09 crore in September 2023.

Reported Standalone quarterly numbers for Contech Software are: Net Sales at Rs 2.32 crore in September 2024 down 43.42% from Rs. 4.10 crore in September 2023. Quarterly Net Profit at Rs. 0.42 crore in September 2024 up 41.94% from Rs. 0.29 crore in September 2023. EBITDA stands at Rs. 0.56 crore in September 2024 up 60% from Rs. 0.35 crore in September 2023.

Reported Standalone quarterly numbers for GEE are: Net Sales at Rs 82.83 crore in September 2024 down 15.04% from Rs. 97.49 crore in September 2023. Quarterly Net Profit at Rs. 1.91 crore in September 2024 down 64.63% from Rs. 5.40 crore in September 2023. EBITDA stands at Rs. 5.81 crore in September 2024 down 41.25% from Rs. 9.89 crore in September 2023.

Reported Standalone quarterly numbers for Bartronics India are: Net Sales at Rs 8.85 crore in September 2024 down 28.79% from Rs. 12.43 crore in September 2023. Quarterly Net Profit at Rs. 0.25 crore in September 2024 up 125.1% from Rs. 0.99 crore in September 2023. EBITDA stands at Rs. 0.26 crore in September 2024 up 204% from Rs. 0.25 crore in September 2023.

Reported Standalone quarterly numbers for Godavari Drugs are: Net Sales at Rs 26.09 crore in September 2024 down 34.03% from Rs. 39.54 crore in September 2023. Quarterly Net Profit at Rs. 1.09 crore in September 2024 up 27.2% from Rs. 0.86 crore in September 2023. EBITDA stands at Rs. 2.91 crore in September 2024 down 4.9% from Rs. 3.06 crore in September 2023.

Reported Standalone quarterly numbers for Kerala Ayurveda are: Net Sales at Rs 20.03 crore in September 2024 up 6.87% from Rs. 18.75 crore in September 2023. Quarterly Net Loss at Rs. 0.54 crore in September 2024 down 205.96% from Rs. 0.51 crore in September 2023. EBITDA stands negative at Rs. 0.16 crore in September 2024 down 120.51% from Rs. 0.78 crore in September 2023.

Gujarat Toolroom Limited's share price surged 4.99% to ₹13.26 after securing a ₹310 million order from Reliance Industries, marking a key milestone in their partnership, with the company expressing optimism for additional orders and having raised ₹50 crore via a Qualified Institutional Placement earlier this year.

Reported Standalone quarterly numbers for Smruthi Organics Limited are: Net Sales at Rs 29.39 crore in September 2024 down 0.68% from Rs. 29.59 crore in September 2023. Quarterly Net Profit at Rs. 0.78 crore in September 2024 down 62.55% from Rs. 2.07 crore in September 2023. EBITDA stands at Rs. 2.90 crore in September 2024 down 34.68% from Rs. 4.44 crore in September 2023.

Reported Standalone quarterly numbers for Desh Rakshak Aushadalaya are: Net Sales at Rs 1.19 crore in September 2024 up 42.33% from Rs. 0.84 crore in September 2023. Quarterly Net Profit at Rs. 0.15 crore in September 2024 up 61.06% from Rs. 0.09 crore in September 2023. EBITDA stands at Rs. 0.33 crore in September 2024 up 3.13% from Rs. 0.32 crore in September 2023.